Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
A Japanese regulatory reform panel has urged the government to submit legislation to the 2027 ordinary Diet session to expand the secondary use of health and medical data that can be utilized without patient consent, drawing on a European framework…
To read the full story
Related Article
REGULATORY
- Lilly’s Oral GLP-1 Obesity Drug Heads to Dec. 2 Panel Review, Eyes Japan First
November 19, 2026
- Pharma Prods LDP to Rethink CEA Expansion, Project Team to Compile Proposal
November 19, 2026
- First Pralia Biosimilars Inching Closer to Japan Approval, 5 Products Lined Up
November 19, 2026
- MHLW Drug Supply Monitoring System Hit by Cyberattack, Possible Data Leak
November 19, 2026
- Japan’s FY2027 AMED Budget Requests Top 450 Billion Yen
November 19, 2026





